Evaluation of the response rate in major depressive disorder after taking citalopram as a predictive factor base on motor cortex magnetic brain stimulation.
Phase 2
- Conditions
- Major Depressive Disorder.Major depressive disorder, recurrent
- Registration Number
- IRCT20100119003106N43
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Diagnosis of major depression by a psychiatrist or by using Hamilton's 24-question questionnaire
Age 18-65 years old
Having written informed consent and and incentive to cooperate and participate in completing the questionnaires provided by the researcher
Not having a history of taking psychiatric drugs in the last 2 weeks
Exclusion Criteria
Unwillingness to continue cooperating in the study and not completing the questionnaire
If the person is suffering from a specific neurological/psychological disorder at the same time
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determining the MEP of patients through TMS. Timepoint: Before taking citalopram and 2 hours after taking citalopram. Method of measurement: Comparison of MEP of patients before and after taking citalopram.
- Secondary Outcome Measures
Name Time Method Hamilton and Beck depression questionnaire. Timepoint: Before taking citalopram and after taking citalopram. Method of measurement: Comparison of Hamilton and beck depression score of patients before and after taking citalopram.